Skip to content
DraconiticResearch
Search Sources API
210,049 studies31 sourcesUpdated 29 min ago

Oncology

5,302 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,302 studies

  1. Hypoxic conditioning of neuroblastoma cells promotes CD8⁺ T-cell dysfunction through the HIF-1α/PD-L1 axis.
    Yujin Chao, Guili Zheng
    Frontiers in pediatricsPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  2. Cellular origins and evolutionary dynamics of plasma cfDNA in solid tumors: integrating germline, tumor-derived, and hematopoietic variation for MRD and treatment guidance.
    Quanneng Zhao, Chunlei Wu, Xiao Huang +2
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  3. Research progress on bowel preparation regimens before colonoscopy: a narrative review.
    Xiang Liao, Yu Song, Yazhi He +3
    Frontiers in medicinePeer-reviewedCC BYFull textOncologyEurope PMCPMC
  4. Abdominal aortic angiosarcoma following endovascular aneurysm repair: case report and analysis of existing literature.
    Loes H Willems, Marcus Steinbach, Daniel Pink +3
    Frontiers in surgeryPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  5. The immunogenicity control axis: a multi-omics framework for integrating epigenetic, DNA damage response, and immune states in cancer.
    Manyata Srivastava, Shishir Singh, Diksha Ameta +3
    Frontiers in geneticsPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  6. Prevalence of anxiety and depression in breast cancer patients: a meta-analysis.
    Chao-Yi Jia, Zhao-Yue Chen, Bei-Te Liu +7
    Frontiers in psychologyPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  7. Radiation-Induced Collagen I&III Accumulation Drives Immunosuppressive Evolution in Recurrent Glioblastoma
    Opeyemi Iwaloye, Lewis Barr, Jun Takei +3
    bioRxivPreprintCC BYFull textOncologybioRxivPMC
  8. Pharmacologic inhibition of OLIG2 by CT-179 disrupts mitotic progression and enhances standard-of-care chemoradiotherapy in glioblastoma
    Sam A. Greenall, Shengnan C. Chen, Gordon Alton +24
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  9. Elevated polyadenylated histone gene transcription in human cancer
    Ronald M. Paranal, Terri D. Bryson, Guillermina Rios Rios +3
    bioRxivPreprintCC BYFull textOncologybioRxivPMC
  10. Metabolically encoded cell-surface glycoRNA remodeling enhances antitumor immunity
    B. Niu, R. Deng, S. Xie +13
    bioRxivPreprintPublic domainFull textOncologybioRxiv
  11. Venetoclax Resistance Creates Canonical Pyroptosis Vulnerability in AML
    Q. Wang, S. Xu, J. Cai +16
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  12. Genomic characterization of patient derived xenograft models of multiple myeloma reveals selection of multiple pre-existing high risk clones
    Nathan J. Becker, Enze Liu, Riya Sharma +23
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivEurope PMCPMC
  13. Rapid Micronucleus-Sequencing (RaMN-Seq) Reveals Patterns of Bias in Induced and Spontaneous Chromosomal Instability
    J. K. Maharaj, I. McNeil, M. A. Guscott +5
    bioRxivPreprintCC BYFull textOncologybioRxiv
  14. Engineering potent avian GPR25 agonists using an ostrich CXCL17 gene relic
    J. Yu, H.-Z. Li, J.-J. Wang +2
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  15. Targeting TMPRSS2-ERG Fusion-Driven Prostate Cancer using Novel HBS-α-Helicomimics
    S. Kundu, P. Ganguly, L. Varte +3
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  16. "It's Like a Marathon": A Qualitative Study of Symptom Burden and Adaptation Among Patients with Oxaliplatin-Induced Peripheral Neuropathy During Treatment.
    Yi Zhang, Jing Han, Wen Gong +1
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMC
  17. Immune Checkpoint Inhibitor-Associated Pneumonitis in Patients Treated for Metastatic Renal Cell Carcinoma.
    Jack Masur, Abhishek Mullapudi, Soham Ali +10
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMC
  18. Nationwide HER2 Testing, Prospective Trastuzumab-Based Therapy, and Deep Visual Proteomics in Esophageal Squamous Cell Carcinoma
    K. Egebjerg, E. Chelebian, L. Baeksgaard +14
    medRxivPreprintCC BYFull textOncologymedRxiv
  19. Does the Disease-free Survival Benefit of Adding Belzutifan to Adjuvant Pembrolizumab Persist Beyond the Planned Treatment Period? A Reconstructed Individual Patient Data Analysis of Phase 3 Renal Cell Carcinoma Trials
    H.-H. Chang, C.-K. Chang, T.-Y. Tang +12
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  20. Genomic correlates with survival after treatment of oesophageal adenocarcinoma by surgery alone
    A. Trinh, T. P. Udumanne, S. J. Lord +14
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  21. Correlation of Axillary Nodal with Breast Response Following Neoadjuvant Chemotherapy in Early Breast Cancer
    A. Agrawal, M. Soliman, B. Ahmed +2
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  22. Self-supervised pretraining for dermoscopic lesion segmentation with limited labels: A controlled comparison of initialisation strategies
    H. K. H. Hamda, S. Mustafa, G. Khalili Moghaddam
    medRxivPreprintCC BYFull textOncologymedRxiv
  23. No decline in functional status or cognitive function during the first year after treatment initiation for early-stage breast cancer in women aged 75 years and older: a prospective observational matched cohort study
    W. G. van der Plas-Krijgsman, J. W. Blom, M. G. M. Derks +12
    medRxivPreprintCC BYFull textOncologymedRxiv
  24. Differential risk and protective factors for conventional adenomas and serrated lesions: implications for colorectal cancer prevention
    Junjie Cai, Yiliu Huang, Yi Luo +3
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  25. Associations of cumulative occupational benzene exposure with genotoxic and immunosenescence-related biomarkers: a cross-sectional study
    Wenqian Xu, Xiaoying Ruan, Lu He +2
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC